News & Perspective
Drugs & Diseases
CME & Education
Academy
Video
Decision Point

Specialty: Multispecialty
Allergy & Immunology
Anesthesiology
Cardiology
Critical Care
Dermatology
Diabetes & Endocrinology
Emergency Medicine
Family Medicine
Gastroenterology
General Surgery
Hematology - Oncology
HIV/AIDS
Hospital Medicine
Infectious Diseases
Internal Medicine
Multispecialty
Nephrology
Neurology
Ob/Gyn & Women's Health
Oncology
Ophthalmology
Orthopedics
Pathology & Lab Medicine
Pediatrics
Plastic Surgery
Psychiatry
Public Health
Pulmonary Medicine
Radiology
Rheumatology
Transplantation
Urology
Today on Medscape
Business of Medicine
Medical Lifestyle
Science & Technology
Medical Students
Nurses
Pharmacists
Residents
Edition: English

Medscape

English
Deutsch
Español
Français
Português
UKNew

Univadis

Sign Up It's Free!
English Edition

Medscape

Univadis

    X
    Univadis from Medscape

    No Results

      Wednesday, December 27, 2023
      News & Perspective Drugs & Diseases CME & Education Academy Video Decision Point

      From theheart.org on Medscape

      Coverage from the

      Transcatheter Cardiovascular Therapeutics (TCT) 2021

      November 04 - 06, 2021; Orlando, FL, and Virtual

      November 04 - 06, 2021 Orlando, FL, and Virtual

      Conference News

      News from TCT 2020

      • Ticagrelor Monotherapy Beats DAPT in STEMI Ticagrelor Monotherapy Beats DAPT in STEMI Ticagrelor monotherapy after 3 months of dual-antiplatelet therapy in patients with ST-elevation myocardial infarction treated with drug-eluting stents proved a winning strategy in TICO-STEMI.
        Medscape Medical News, Oct 15, 2020
      • MitraClip Effective for Post-MI Acute MR With Cardiogenic Shock MitraClip Effective for Post-MI Acute MR With Cardiogenic Shock Percutaneous mitral valve repair with the MitraClip appears to be a safe, effective, and life-saving treatment for severe acute MR secondary to MI in surgical noncandidates, according to IREMMI data.
        Medscape Medical News, Oct 19, 2020
      • TAVR in Degenerated TAVR Valve Works in 'No Option' Patients TAVR in Degenerated TAVR Valve Works in 'No Option' Patients A 'TAVR-in-TAVR' registry of nonsurgical patients could lead one day to a transcatheter option for today's low-risk TAVR patients who may still be acceptable for surgery when their first valve fails.
        Medscape Medical News, Oct 20, 2020

      © WebMD, LLC

      Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.

      Previous Coverage

      Find Us On
      About
      About Medscape Privacy Policy Editorial Policy Cookies Terms of Use Advertising Policy Help Center
      Membership
      Become a Member About You Professional Information Newsletters & Alerts Market Research
      App
      Medscape
      WebMD Network
      Medscape Live Events WebMD MedicineNet eMedicineHealth RxList WebMD Corporate Medscape UK
      Editions
      English Deutsch Español Français Português UK
      All material on this website is protected by copyright, Copyright © 1994-2023 by WebMD LLC. This website also contains material copyrighted by 3rd parties.